These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26205654)

  • 1. Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells.
    Li D; Xu D; Lu Z; Dong X; Wang X
    Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26205654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
    Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
    Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
    Hempel N; How T; Cooper SJ; Green TR; Dong M; Copland JA; Wood CG; Blobe GC
    Carcinogenesis; 2008 May; 29(5):905-12. PubMed ID: 18299279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
    Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
    Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
    Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
    Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.
    Yan Z; Deng X; Friedman E
    J Biol Chem; 2001 Jan; 276(2):1555-63. PubMed ID: 11029459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts.
    Meng W; Xia Q; Wu L; Chen S; He X; Zhang L; Gao Q; Zhou H
    BMC Cancer; 2011 Feb; 11():88. PubMed ID: 21352603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma.
    Wang N; Wang Q; Chi J; Xiang F; Lin M; Wang W; Wei F; Feng Y
    Cancer Sci; 2019 Feb; 110(2):519-529. PubMed ID: 30565803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma.
    Kim SG; Song JY
    Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
    O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
    Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
    Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
    Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of TβRIII facilitates the osteogenesis of supraspinous ligament-derived fibroblasts from patients with ankylosing spondylitis.
    Zhang Y; Chen WG; Yang SZ; Qiu H; Hu X; Qiu YY; Wen X; Zhou Y; Chu TW
    J Cell Mol Med; 2021 Feb; 25(3):1613-1623. PubMed ID: 33410269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
    Criswell TL; Dumont N; Barnett JV; Arteaga CL
    Cancer Res; 2008 Sep; 68(18):7304-12. PubMed ID: 18794117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
    Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III TGF-β receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-κB signaling.
    Xu D; Li D; Lu Z; Dong X; Wang X
    Oncol Rep; 2016 Jan; 35(1):267-74. PubMed ID: 26531330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.